A 1-year trial of repeated high-dose intravenous iron isomaltoside 1000 to maintain stable hemoglobin levels in inflammatory bowel disease

Objective. Iron isomaltoside 1000 (Monofer®) is a high-dose intravenous (IV) iron, which in a recent 8 weeks trial in inflammatory bowel disease (IBD) subjects with iron deficiency anemia (IDA) demonstrated good tolerability and efficacy. The present trial is an extension to this trial, which evalua...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Scand J Gastroenterol
Главные авторы: Reinisch, Walter, Altorjay, Istvan, Zsigmond, Ferenc, Primas, Christian, Vogelsang, Harald, Novacek, Gottfried, Reinisch, Sieglinde, Thomsen, Lars L.
Формат: Artigo
Язык:Inglês
Опубликовано: Taylor & Francis 2015
Предметы:
Original Article
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC4673551/
https://ncbi.nlm.nih.gov/pubmed/25900645
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/00365521.2015.1031168
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы